HEALTHCARE UTILIZATION, EXPENDITURES, AND HEALTH-RELATED QUALITY OF LIFE AMONG U.S. ADULTS WITH RHEUMATOID ARTHRITIS AND COMORBID HYPERTENSION: MEDICAL EXPENDITURE PANEL SURVEY, 2020-2023

Author(s)

Samruddhi Nandkumar Borate, M.Pharm, Akhila Yerubandi, PharmD, Lorenzo Villa Zapata, PharmD, PhD;
University of Georgia College of Pharmacy, Department of Clinical and Administrative Pharmacy, Athens, GA, USA
OBJECTIVES: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with high healthcare utilization and reduced physical functioning. Hypertension (HTN), a common and modifiable cardiovascular comorbidity in RA, may further increase disease burden and healthcare needs. This study compared healthcare utilization, expenditures, and health-related quality of life among US adults with RA with and without comorbid HTN.
METHODS: We conducted a cross-sectional analysis of pooled 2020-2023 Medical Expenditure Panel Survey (MEPS) data. Adults with RA were identified from the Medical Conditions file and classified as RA-only or RA+HTN. Survey-weighted descriptive analyses compared socio-demographics, healthcare utilization, expenditures, and health-related quality of life between groups. Group differences were assessed within the RA subpopulation using survey-weighted linear regression and the Rao-Scott chi-square test for categorical outcomes.
RESULTS: Among U.S. adults with RA (weighted population approximately 4.3 million), 49.7% had comorbid hypertension. Compared with RA-only, those with RA+HTN were older (mean difference, 7.2 years; p<0.001) and reported worse physical health-related quality of life (mean physical component summary score difference, −3.9 points; p<0.001), whereas mental health scores did not differ (p=0.20). Adults with RA+HTN had higher healthcare utilization, including more office-based visits (mean difference, +2.5 visits; p=0.02) and greater prescription medication use (mean difference, +17.2 fills; p<0.001). Mean unadjusted annual total healthcare expenditures were higher for RA+HTN than RA-only ($28,088 vs $23,006), although the difference was not statistically significant (p=0.10). No significant differences were observed in other unadjusted expenditure components (office-based, outpatient, inpatient, prescription, and emergency department).
CONCLUSIONS: Hypertension is common among U.S. adults with rheumatoid arthritis and is associated with higher healthcare utilization and poorer physical health-related quality of life. These findings support attention to cardiovascular comorbidity management as part of comprehensive RA care.

Conference/Value in Health Info

2026-05, ISPOR 2026, Philadelphia, PA, USA

Value in Health, Volume 29, Issue S6

Code

EE28

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

SDC: Cardiovascular Disorders (including MI, Stroke, Circulatory), SDC: Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal)

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×